07/14/2025
10:51 AM | Allarity Therapeutics (Issuer)
Ervin Jeffrey S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/07/2025
7:43 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
3:05 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2025
7:07 AM | Allarity Therapeutics (Filer)
| Form RW | |
06/11/2025
3:10 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
7:09 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
7:05 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
4:27 PM | Allarity Therapeutics (Filer)
| Form DEF 14A | |
04/30/2025
4:28 PM | Allarity Therapeutics (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for ALLR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Allarity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/28/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
7:17 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
7:06 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2025
6:55 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
7:07 PM | Allarity Therapeutics (Issuer)
McLaughlin Gerald W. (Reporting)
| Form 4/A | |
01/24/2025
7:09 PM | Allarity Therapeutics (Issuer)
Benjamin Laura (Reporting)
| Form 4/A | |
01/24/2025
7:10 PM | Allarity Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
| Form 4/A | |
01/24/2025
3:12 PM | Allarity Therapeutics (Issuer)
Benjamin Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:13 PM | Allarity Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:14 PM | Allarity Therapeutics (Issuer)
McLaughlin Gerald W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:16 PM | Allarity Therapeutics (Issuer)
Jensen Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:17 PM | Allarity Therapeutics (Issuer)
Epshinsky Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:18 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:17 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
8:24 PM | 3i, LP (Filed by)
Allarity Therapeutics (Subject)
| Form SC 13G/A | |
10/23/2024
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
4:32 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
4:34 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:05 PM | Allarity Therapeutics (Issuer)
Epshinsky Alexander (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/17/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
7:53 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
8:15 AM | Allarity Therapeutics (Filer)
| Form 8-K/A | |
Revolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial Underway (Ad) Tiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare! Discover how this tiny tech firm is using AI in healthcare |
09/09/2024
8:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
4:57 PM | Allarity Therapeutics (Subject)
Olmsted Investments LLC (Filed by)
| Form SCHEDULE 13G | |
08/21/2024
3:55 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
4:24 PM | Allarity Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
5:04 AM | Allarity Therapeutics (Filer)
| Form DEFA14A | |
07/23/2024
3:05 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
5:03 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
